pyrazines has been researched along with syringolin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachmann, AS; Clerc, J; Driessen, C; Dudler, R; Florea, BI; Groll, M; Huber, R; Kaiser, M; Kraus, M; Overkleeft, HS | 1 |
| Bachmann, AS; Ibarra-Rivera, TR; Opoku-Ansah, J; Pirrung, MC | 1 |
2 other study(ies) available for pyrazines and syringolin a
| Article | Year |
|---|---|
Syringolin A selectively labels the 20 S proteasome in murine EL4 and wild-type and bortezomib-adapted leukaemic cell lines.
Topics: Animals; Boronic Acids; Bortezomib; Cell Line, Tumor; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Peptides, Cyclic; Proteasome Endopeptidase Complex; Pyrazines; Spectrometry, Mass, Electrospray Ionization | 2009 |
Syringolin B-inspired proteasome inhibitor analogue TIR-203 exhibits enhanced biological activity in multiple myeloma and neuroblastoma.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Multiple Myeloma; Neuroblastoma; Peptides, Cyclic; Proteasome Inhibitors; Pyrazines; Urea | 2012 |